An innovative specialty pharmaceutical company focused on responsible pain management and the development of abuse-deterrent products for multiple specialties.

TALPHERA (previously AcelRx Pharmaceuticals, Inc.) is a specialty drug device company focused on developing and commercializing innovative therapies for use in medically supervised settings. Built a commercial team in the acute care, hospital, ambulatory surgery centers, and in-office procedural suites● Successfully sold drug-device to Alora Pharmaceuticals● Sales Growth of 141% YOY (Q1 2021 vs Q1 2022)● Achieved 750+ formulary wins and new accounts exceeding the corporate goal of 625 accounts● Shifted targeting and KPIs to procedural suites vs hospitals to speed up the ordering process● Pivoted to a new sales model, including, a single decision maker, virtual sales, and programming that generated additional leads that led to all-time quarterly highs in new accounts in 2021

Biopharmaceutical Company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Responsible for building and leading US Commercial Operations team of NeuroHealth Specialty Leaders and Sales Professionals.● Exceeded net sales YOY growth increase + 96% 2016 vs 2015, 117% of corporate forecast● Increased sales from $6 million to $64 million in 2 years, exceeding forecast and coming in below budget. Achievements completed without payer contracts in place.● Consistently achieve a 90%+ engagement score through culture building and collaboration work streams resulting in extremely high retention rates● Strategically planned and built a 135 footprint Neuroscience commercial sales infrastructure

Research-based pharmaceutical company developing and promoting medicines in cardiovascular, Respiratory, Neuroscience, Oncology and Vaccines. Role was sales leadership for a 10 state region.● Grew to the most profitable region in the nation, 32% GTN, ($408 million net revenue) by collaboration with unique state healthcare markets and multiple community leaders, including CEOs of health systems, state governments, and nationally recognized physician thought leaders● Successfully led a team of sales professionals and fourteen direct reports including sales, marketing, and operations to exceed goals and expectations by 124%● Restructured key roles that had better impact with target health systems leading the region to be the most profitable in the nation.● Moved the region to a commercial 3rd party focus versus the previous less profitable focused workstreams

Rapidly growing cardiovascular pharmaceutical company specializing in the development, commercialization, and marketing of prescription cardiovascular therapies (Acquired by GlaxoSmithKline in 2007) Moved into greater levels of responsibility, including Regional Sales Director, National Sales Director, and VP Sales.● As Vice President of Sales, exceeded sales forecasts in both 2006-2007 by 134% and 111%, respectively● Leadership responsibilities focused on achieving sales forecast through operation and management of sales budget and team of 800 footprint sales team● Developed engaged culture with highly effective sales strategies, the new start-up reached top tier status in the industry – Verispan Noted that Reliant sales team emerging with a rank of 26 out of Top 60 Pharma companies and Cardiology team ascending to rank of 14